<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JDM</journal-id><journal-title-group><journal-title>Journal of Diabetes Mellitus</journal-title></journal-title-group><issn pub-type="epub">2160-5831</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jdm.2022.124019</article-id><article-id pub-id-type="publisher-id">JDM-121109</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Health Related Quality of Life in Adult with Type 2 Diabetes Mellitus
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Md.</surname><given-names>Motiur Rahman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hafiza</surname><given-names>Sultana</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Farkhanda</surname><given-names>Mah Jebin</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tanmoy</surname><given-names>Saha</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wahida</surname><given-names>Yasmeen</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Foisal</surname><given-names>Mohammad Mosiul Alom</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Syeda</surname><given-names>Tahmina Ferdous Jinia</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Syed</surname><given-names>Ahmed</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Laiak</surname><given-names>Ahammed</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Khwaja Yunus Ali Medical College, Sirajganj, Bangladesh</addr-line></aff><aff id="aff8"><addr-line>Bangabandhu Sheikh Mujib Medical College, Fraidpur, Bangladesh</addr-line></aff><aff id="aff5"><addr-line>Udayan Dental College, Rajshahi, Bangladesh</addr-line></aff><aff id="aff2"><addr-line>National Institute of Preventive &amp;amp; Social Medicine (NIPSOM), Dhaka, Bangladesh</addr-line></aff><aff id="aff4"><addr-line>Tooth Fairy Foundation, Dhaka, Bangladesh</addr-line></aff><aff id="aff7"><addr-line>Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh</addr-line></aff><aff id="aff1"><addr-line>Sheikh Sayera Khatun Medical College and Hospital, Gopalganj, Bangladesh</addr-line></aff><aff id="aff6"><addr-line>National Institute of Traumatology and Orthopaedic Rehabilitation (NITOR), Dhaka, Bangladesh</addr-line></aff><pub-date pub-type="epub"><day>19</day><month>10</month><year>2022</year></pub-date><volume>12</volume><issue>04</issue><fpage>243</fpage><lpage>251</lpage><history><date date-type="received"><day>3,</day>	<month>September</month>	<year>2022</year></date><date date-type="rev-recd"><day>7,</day>	<month>November</month>	<year>2022</year>	</date><date date-type="accepted"><day>10,</day>	<month>November</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: The health related quality of life (HRQoL) has an important role in adults suffering from diabetes. 
  Objective: To assess the health related quality of life in adult with type 2 diabetes mellitus. 
  Materials and methods: A cross-sectional study was conducted to assess diabetic patient’s HRQoL on 119 purposively selected type-2 DM patients (aged ≥ 18 years and duration of diabetes ≥ 1 year). Data were collected by face-to-face interview and by medical record review through a Bangle version of SF-36 semi-structured questionnaire and a checklist.
   Place and period of study: The study was conducted at outpatient department in Gopalganj 50 bedded diabetic hospital from 1
  <sup>st</sup> January, 2018 to 31
  <sup>st</sup> December 2018. 
  Results: The mean age of the respondents was 52.34 (SD &#177; 10.19) years. Age group shows a significant difference associated with all domains of quality of life except role emotion (&gt;0.05), gender shows the significant in social and pain domain (&lt;0.05). Physical functioning and role physical also show the significant associated with education. Duration of diabetes and use of oral hypoglycemic agent shows the significant difference (&lt;0.05) associated with all domains of quality of life except role physical and role emotion (&gt;0.05) respectively co-morbidity shows the significant difference with all domains expect pain (&gt;0.05). Physical functioning, emotional, pain and general health of the quality of life show the significant difference associated with use of insulin (&lt;0.05). 
  Conclusion: The overall QoL of type-2 DM patients was poor and had lower score of health related quality of life.
 
</p></abstract><kwd-group><kwd>Type 2 Diabetes Mellitus</kwd><kwd> Health Related Quality of Life</kwd><kwd> Diabetes Mellitus</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>An especially essential aspect of life for persons with diabetes mellitus is quality of life. Diabetes influences almost every facet of life; contain food, activity, work, and daily routines [<xref ref-type="bibr" rid="scirp.121109-ref1">1</xref>]. Type 2 diabetes mellitus place greater world-wide health threaten, particularly in improved and underdeveloped countries [<xref ref-type="bibr" rid="scirp.121109-ref2">2</xref>]. The worldwide predominance of diabetes mellitus in adults has been growing over modern decades [<xref ref-type="bibr" rid="scirp.121109-ref3">3</xref>].</p><p>According to the International Diabetes Federation report of 2015, around 415 million nations have DM globally, with the figure projected to have increased to 642 million by 2040 or possibly even twofold by the year 2040. The greatest extent will be in underdeveloped countries (69%) compare with developed countries (20%), with the non-communicable disease (NCDs) accounting for up to 80% of deaths among underdeveloped countries [<xref ref-type="bibr" rid="scirp.121109-ref4">4</xref>].</p><p>According to the IDF Diabetes Atlas, almost one-fifth of the world population with diabetes mellitus lives in South East Asia country. This report indicates that the number of people with DM will increase to 120.9 million by 2030 that is 10.2% of the adult population will have diabetes. The predominance of DM is higher in upper-middle-income countries (10.1%) compare to lower middle-income countries (8.6%) and it is described that four out of five people with DM live in low- and middle-income countries. About 291 million out of the 3.6 billion adults with diabetes are generally living in low- and middle-income countries, compared to 75 million in high-income countries [<xref ref-type="bibr" rid="scirp.121109-ref5">5</xref>].</p><p>In Bangladesh, the total count of people with DM is designed to rise from 3.2 million in 2000 to 11.1 million in 2030 [<xref ref-type="bibr" rid="scirp.121109-ref6">6</xref>]. Another study shows that diabetes patients were 5.10 million in Bangladesh in 2013, which is expected to increase to 8.20 million by 2035 [<xref ref-type="bibr" rid="scirp.121109-ref6">6</xref>]. In the case of uncontrolled diabetes, it chronically increased blood sugar concentrations, which, if left untreated, can result in impairing blood vessels and nerves. This increases the risk of co-morbidities and complications such as macro-vascular complications (e.g. myocardial infarct, angina pectoris, stroke, renal dysfunction and diabetic foot syndrome and amputation) and microvascular complications (e.g. neuropathy, renal disorder, and retinopathy) Diabetes mellitus induces to limitations in attribute of life and in life expectation [<xref ref-type="bibr" rid="scirp.121109-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.121109-ref5">5</xref>].</p><p>Diabetes mellitus is a type of chronic illnesses as the management is troublesome, and the complications are a life-threatening character to the quality of life of the patient [<xref ref-type="bibr" rid="scirp.121109-ref2">2</xref>]. The main purpose of using and measuring health-related quality of life (HRQoL) is to contribute a more exhaustive assessment, oblation a more perfect and valid evaluation of the health of an individual (or group), as well as a more correct estimation of the possible profit and danger of medical consideration [<xref ref-type="bibr" rid="scirp.121109-ref3">3</xref>].</p><p>Quality of life (QOL) is a central issue for patients, providers, and policy makers, and interest in health-related quality of life (HRQOL) has increased markedly in recent years [<xref ref-type="bibr" rid="scirp.121109-ref7">7</xref>]. Against this background, the present study was conducted to assess the HR-QoL of Bangladeshi patients with type 2 diabetes.</p></sec><sec id="s2"><title>2. Methods and Materials</title><p>A hospital-based cross-sectional study was conducted in the outpatient department (OPD) of Gopalganj 50 bedded diabetic hospital. The study was conducted from 1<sup>st</sup> January, 2018 to 31<sup>st</sup> December, 2018. The study population consisted of 119 type 2 diabetes patients (aged ≥ 18 years and above and duration of diabetes ≥ 1 year) including both male and female attending at OPD and willing to give informed consent. Not willing to participate in this study, severe ill patients and Diabetes with pregnancy were not included in this study. Respondents were selected by a purposive sampling method. Data were collected by face-to-face interview and by medical record review through a Bangle version of SF-36 semi-structured questionnaire and a checklist to assess the health-related quality of life. IBM-SPSS version 21 was used for the analysis of data. Descriptive statistics including frequency, percentage, means, medians, mode, and standard deviation were done. To compare the group mean differences, inferential statistics including t-test and one-way ANOVA test were done. For in all the tests, p &lt; 0.05 was considered to be statistically significant. Ethical clearance was obtained from the Institutional Review Board (IRB) of NIPSOM.</p></sec><sec id="s3"><title>3. Results</title><p>Out of (119) patients with T2DM, mean age was 52.34 &#177; 10.19 years (SD). Male were 53% and rest were female (47%). Majority of the respondent’s educational qualification were secondary level education (37.0) and rest of the respondent's educational qualification were graduation and above (10.1%). Mean duration of the diabetes were 5.55&#177; 4.43 years (SD). Most of the respondents follow diet &amp; exercise (88.2%) and rest of the respondents do not maintain diet &amp; exercise discipline (11.8%). Majority of the respondents used oral hypoglycemic agent (56.3%) for diabetes control and rest of the respondents use insulin (43.7%). Among the respondents, 76.5% had co-morbidities and rest of the respondents had no any co-morbidity (23.5%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>The significant difference of mean score of physical functioning in relation to sociodemographic characteristics are found in age group (F = 3.728, P = 0.013) and level of education (F = 3.313, P = 0.013). Role limitations due to physical health were statistically significant in relation to level of education (F = 3.177, 0.016) of the respondents. Mean score of energy/fatigue in relation to age group</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic and clinical characteristics of study participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Age group (years)</td><td align="center" valign="middle" >30 - 40 40 - 50 50 - 60 ≥60</td><td align="center" valign="middle" >10 33 40 36</td><td align="center" valign="middle" >8.4 27.7 33.6 30.3</td></tr><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" >Male Female</td><td align="center" valign="middle" >63 56</td><td align="center" valign="middle" >53 47</td></tr><tr><td align="center" valign="middle" >Educational Qualification</td><td align="center" valign="middle" >Illiterate Up-to Primary Secondary Higher Secondary Graduation &amp; Above</td><td align="center" valign="middle" >16 34 44 13 12</td><td align="center" valign="middle" >13.4 28.6 37 10.9 10.1</td></tr><tr><td align="center" valign="middle" >Duration of diabetes</td><td align="center" valign="middle" >1 - 4 5 - 9 ≥10</td><td align="center" valign="middle" >61 35 23</td><td align="center" valign="middle" >51.3 29.4 19.3</td></tr><tr><td align="center" valign="middle" >Diet and exercise</td><td align="center" valign="middle" >Yes No</td><td align="center" valign="middle" >105 14</td><td align="center" valign="middle" >88.2 11.8</td></tr><tr><td align="center" valign="middle" >Treatment profile</td><td align="center" valign="middle" >Oral Hypoglycemic Agent (metfomin, gliclazide) Insulin</td><td align="center" valign="middle" >67 52</td><td align="center" valign="middle" >56.3 43.7</td></tr><tr><td align="center" valign="middle" >Co-morbidities</td><td align="center" valign="middle" >Yes No</td><td align="center" valign="middle" >91 28</td><td align="center" valign="middle" >76.5 23.5</td></tr></tbody></table></table-wrap><p>of the respondents (F = 4.634, P = 0.004) was significant. Age (F = 3.206, P = 0.026) of the respondents (F = 2.776, P = 0.030) were significant related to emotional well-being. Social functioning was significant in relation to age group of the respondents (F = 4.989, P = 0.003) and sex of the respondents (t = −2.015, P = 0.046). The test statistics showed that the significant difference of mean score of pain in relation to sociodemographic characteristics are found in the age group (F = 3.928, P = 0.010) and sex of the respondents (t = 2.408, P = 0.018). The significant difference of mean score of general health in relation to sociodemographic characteristics is found in age group (F = 4.442, P = 0.005) and sex (between male and female) of the respondents (t = 2.01, P = 0.046) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Duration of diabetes and use of oral hypoglycemic agent shows the significant difference (&lt;0.05) associated with all domain of quality of life except role physical and role emotion (&gt;0.05) respectively co-morbidity shows the significant difference with all domain expect pain (&gt;0.05) and following diet and exercise also shows the significant difference associated with domain of energy (&lt;0.05). Physical functioning, emotional, pain and general health of the quality of life shows the significant difference associated with Use of insulin (&lt;0.05) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Association of health related quality of life and socio-demographic characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Physical Functioning</th><th align="center" valign="middle" >Role Physical</th><th align="center" valign="middle" >Role Emotion</th><th align="center" valign="middle" >Energy</th><th align="center" valign="middle" >Emotional</th><th align="center" valign="middle" >Social</th><th align="center" valign="middle" >Pain</th><th align="center" valign="middle" >General Health</th></tr></thead><tr><td align="center" valign="middle"  colspan="9"  >Age (Years)</td></tr><tr><td align="center" valign="middle" >30-40</td><td align="center" valign="middle" >51.12 &#177; 23.43</td><td align="center" valign="middle" >57.50 &#177; 23.71</td><td align="center" valign="middle" >53.33 &#177; 23.30</td><td align="center" valign="middle" >48.50 &#177; 24.15</td><td align="center" valign="middle" >54.60 &#177; 11.93</td><td align="center" valign="middle" >67.50 &#177; 27.76</td><td align="center" valign="middle" >59.00 &#177; 26.48</td><td align="center" valign="middle" >38.50 &#177; 17.80</td></tr><tr><td align="center" valign="middle" >40-50</td><td align="center" valign="middle" >59.57 &#177; 29.61</td><td align="center" valign="middle" >52.27 &#177; 28.20</td><td align="center" valign="middle" >51.51 &#177; 22.19</td><td align="center" valign="middle" >54.24 &#177; 15.81</td><td align="center" valign="middle" >57.93 &#177; 9.70</td><td align="center" valign="middle" >71.96 &#177; 20.97</td><td align="center" valign="middle" >53.78 &#177; 23.20</td><td align="center" valign="middle" >36.96 &#177; 16.10</td></tr><tr><td align="center" valign="middle" >50-60</td><td align="center" valign="middle" >52.87 &#177; 27.05</td><td align="center" valign="middle" >56.25 &#177; 21.54</td><td align="center" valign="middle" >55.83 &#177; 25.47</td><td align="center" valign="middle" >49.37 &#177; 15.56</td><td align="center" valign="middle" >53.40 &#177; 9.08</td><td align="center" valign="middle" >55.62 &#177; 21.91</td><td align="center" valign="middle" >45.81 &#177; 21.69</td><td align="center" valign="middle" >36.33 &#177; 15.81</td></tr><tr><td align="center" valign="middle" >≥60</td><td align="center" valign="middle" >41.40 &#177; 21.47</td><td align="center" valign="middle" >41.66 &#177; 21.54</td><td align="center" valign="middle" >47.22 &#177; 24.39</td><td align="center" valign="middle" >39.44 &#177; 17.10</td><td align="center" valign="middle" >50.88 &#177; 9.30</td><td align="center" valign="middle" >55.55 &#177; 17.78</td><td align="center" valign="middle" >37.91 &#177; 21.68</td><td align="center" valign="middle" >25.97 &#177; 12.11</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >0.064</td><td align="center" valign="middle" >0.485</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >.026</td><td align="center" valign="middle" >0.003</td><td align="center" valign="middle" >0.010</td><td align="center" valign="middle" >0.005</td></tr><tr><td align="center" valign="middle"  colspan="9"  >Gender</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >56.04 &#177; 26.79</td><td align="center" valign="middle" >53.96 &#177; 21.15</td><td align="center" valign="middle" >53.96 &#177; 21.15</td><td align="center" valign="middle" >47.61 &#177; 18.09</td><td align="center" valign="middle" >54.53 &#177; 10.09</td><td align="center" valign="middle" >57.34 &#177; 22.18</td><td align="center" valign="middle" >51.50 &#177; 26.56</td><td align="center" valign="middle" >30.87 &#177; 14.46</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >48.40 &#177; 28.98</td><td align="center" valign="middle" >47.32 &#177; 29.64</td><td align="center" valign="middle" >47.32 &#177; 29.64</td><td align="center" valign="middle" >47.67 &#177; 17.39</td><td align="center" valign="middle" >53.42 &#177; 9.60</td><td align="center" valign="middle" >65.40 &#177; 21.31</td><td align="center" valign="middle" >41.38 &#177; 17.85</td><td align="center" valign="middle" >36.60 &#177; 16.57</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >0.138</td><td align="center" valign="middle" >0.159</td><td align="center" valign="middle" >0.159</td><td align="center" valign="middle" >0.985</td><td align="center" valign="middle" >0.541</td><td align="center" valign="middle" >0.046</td><td align="center" valign="middle" >0.018</td><td align="center" valign="middle" >0.046</td></tr><tr><td align="center" valign="middle"  colspan="9"  >Education</td></tr><tr><td align="center" valign="middle" >Illiterate</td><td align="center" valign="middle" >36.87 &#177; 28.97</td><td align="center" valign="middle" >31.25 &#177; 21.40</td><td align="center" valign="middle" >43.75 &#177; 26.44</td><td align="center" valign="middle" >50.93 &#177; 16.35</td><td align="center" valign="middle" >55.50 &#177; 9.67</td><td align="center" valign="middle" >64.84 &#177; 19.48</td><td align="center" valign="middle" >42.18 &#177; 22.05</td><td align="center" valign="middle" >36.25 &#177; 14.20</td></tr><tr><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >49.44 &#177; 25.41</td><td align="center" valign="middle" >55.14 &#177; 27.37</td><td align="center" valign="middle" >53.92 &#177; 23.23</td><td align="center" valign="middle" >50.29 &#177; 14.92</td><td align="center" valign="middle" >53.41 &#177; 9.28</td><td align="center" valign="middle" >62.86 &#177; 23.12</td><td align="center" valign="middle" >44.33 &#177; 16.81</td><td align="center" valign="middle" >32.79 &#177; 16.84</td></tr><tr><td align="center" valign="middle" >SSC</td><td align="center" valign="middle" >60.23 &#177; 25.30</td><td align="center" valign="middle" >51.13 &#177; 24.68</td><td align="center" valign="middle" >52.27 &#177; 22.03</td><td align="center" valign="middle" >46.59 &#177; 17.77</td><td align="center" valign="middle" >53.27 &#177; 9.40</td><td align="center" valign="middle" >63.35 &#177; 22.45</td><td align="center" valign="middle" >50.96 &#177; 28.15</td><td align="center" valign="middle" >34.31 &#177; 16.62</td></tr><tr><td align="center" valign="middle" >HSC</td><td align="center" valign="middle" >42.69 &#177; 31.66</td><td align="center" valign="middle" >55.76 &#177; 23.17</td><td align="center" valign="middle" >51.28 &#177; 25.87</td><td align="center" valign="middle" >40.38 &#177; 18.87</td><td align="center" valign="middle" >52.92 &#177; 6.76</td><td align="center" valign="middle" >50.96 &#177; 20.06</td><td align="center" valign="middle" >40.19 &#177; 16.90</td><td align="center" valign="middle" >30.38 &#177; 12.49</td></tr><tr><td align="center" valign="middle" >Graduation &amp; above</td><td align="center" valign="middle" >63.75 &#177; 29.16</td><td align="center" valign="middle" >58.33 &#177; 22.19</td><td align="center" valign="middle" >55.55 &#177; 29.58</td><td align="center" valign="middle" >47.50 &#177; 24.44</td><td align="center" valign="middle" >57.66 &#177; 15.29</td><td align="center" valign="middle" >54.16 &#177; 21.54</td><td align="center" valign="middle" >51.25 &#177; 27.10</td><td align="center" valign="middle" >32.91 &#177; 15.44</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >0.016</td><td align="center" valign="middle" >0.674</td><td align="center" valign="middle" >0.459</td><td align="center" valign="middle" >0.631</td><td align="center" valign="middle" >0.282</td><td align="center" valign="middle" >0.428</td><td align="center" valign="middle" >0.881</td></tr></tbody></table></table-wrap><p>*Data presented as Mean &#177; SD, P &lt; 0.05 is considered as statistical significant value.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Association of health related quality of life and clinical variables</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Physical Functioning</th><th align="center" valign="middle" >Role Physical</th><th align="center" valign="middle" >Role Emotion</th><th align="center" valign="middle" >Energy</th><th align="center" valign="middle" >Emotional</th><th align="center" valign="middle" >Social</th><th align="center" valign="middle" >Pain</th><th align="center" valign="middle" >General Health</th></tr></thead><tr><td align="center" valign="middle"  colspan="9"  >Duration of diabetes</td></tr><tr><td align="center" valign="middle" >1 - 4</td><td align="center" valign="middle" >56.66 &#177; 28.61</td><td align="center" valign="middle" >52.04 &#177; 27.11</td><td align="center" valign="middle" >49.18 &#177; 22.44</td><td align="center" valign="middle" >49.26 &#177; 17.22</td><td align="center" valign="middle" >54.75 &#177; 9.39</td><td align="center" valign="middle" >65.57 &#177; 22.55</td><td align="center" valign="middle" >50.36 &#177; 25.21</td><td align="center" valign="middle" >37.29 &#177; 16.37</td></tr><tr><td align="center" valign="middle" >5 - 9</td><td align="center" valign="middle" >60.28 &#177; 21.34</td><td align="center" valign="middle" >52.85 &#177; 24.07</td><td align="center" valign="middle" >58.09 &#177; 27.22</td><td align="center" valign="middle" >50.14 &#177; 18.08</td><td align="center" valign="middle" >56.22 &#177; 9.69</td><td align="center" valign="middle" >60.35 &#177; 19.52</td><td align="center" valign="middle" >46.50 &#177; 18.67</td><td align="center" valign="middle" >31.28 &#177; 14.10</td></tr><tr><td align="center" valign="middle" >≥10</td><td align="center" valign="middle" >29.34 &#177; 23.65</td><td align="center" valign="middle" >44.56 &#177; 23.78</td><td align="center" valign="middle" >49.27 &#177; 22.17</td><td align="center" valign="middle" >39.56 &#177; 16.71</td><td align="center" valign="middle" >48.69 &#177; 9.69</td><td align="center" valign="middle" >50.54 &#177; 21.47</td><td align="center" valign="middle" >37.50 &#177; 22.93</td><td align="center" valign="middle" >27.17 &#177; 13.88</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.424</td><td align="center" valign="middle" >0.186</td><td align="center" valign="middle" >0.048</td><td align="center" valign="middle" >0.011</td><td align="center" valign="middle" >0.019</td><td align="center" valign="middle" >0.078</td><td align="center" valign="middle" >0.017</td></tr><tr><td align="center" valign="middle"  colspan="9"  >Diet and exercise</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >52.34 &#177; 27.71</td><td align="center" valign="middle" >50.47 &#177; 26.16</td><td align="center" valign="middle" >50.47 &#177; 24.07</td><td align="center" valign="middle" >48.90 &#177; 17.36</td><td align="center" valign="middle" >54.28 &#177; 9.99</td><td align="center" valign="middle" >59.76 &#177; 22.46</td><td align="center" valign="middle" >46.61 &#177; 22.86</td><td align="center" valign="middle" >32.71 &#177; 15.17</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >53.21 &#177; 31.10</td><td align="center" valign="middle" >53.57 &#177; 21.61</td><td align="center" valign="middle" >61.90 &#177; 22.09</td><td align="center" valign="middle" >38.21 &#177; 17.93</td><td align="center" valign="middle" >52.00 &#177; 8.59</td><td align="center" valign="middle" >71.42 &#177; 15.83</td><td align="center" valign="middle" >47.67 &#177; 27.69</td><td align="center" valign="middle" >40.00 &#177; 18.50</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >0.914</td><td align="center" valign="middle" >0.673</td><td align="center" valign="middle" >0.095</td><td align="center" valign="middle" >0.033</td><td align="center" valign="middle" >0.416</td><td align="center" valign="middle" >0.063</td><td align="center" valign="middle" >0.874</td><td align="center" valign="middle" >0.103</td></tr><tr><td align="center" valign="middle"  colspan="9"  >Treatment profile</td></tr><tr><td align="center" valign="middle"  colspan="9"  >Oral Hypoglycemic Agent (OHA)</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >60.16 &#177; 27.33</td><td align="center" valign="middle" >52.61 &#177; 24.66</td><td align="center" valign="middle" >51.74 &#177; 24.81</td><td align="center" valign="middle" >50.59 &#177; 18.05</td><td align="center" valign="middle" >56.47 &#177; 9.73</td><td align="center" valign="middle" >64.55 &#177; 22.46</td><td align="center" valign="middle" >51.94 &#177; 23.50</td><td align="center" valign="middle" >36.26 &#177; 15.74</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >42.50 &#177; 25.83</td><td align="center" valign="middle" >48.55 &#177; 26.84</td><td align="center" valign="middle" >51.92 &#177; 23.25</td><td align="center" valign="middle" >43.84 &#177; 16.61</td><td align="center" valign="middle" >50.84 &#177; 9.11</td><td align="center" valign="middle" >56.73 &#177; 20.92</td><td align="center" valign="middle" >40.04 &#177; 21.56</td><td align="center" valign="middle" >30.09 &#177; 15.06</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.394</td><td align="center" valign="middle" >0.968</td><td align="center" valign="middle" >0.038</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.055</td><td align="center" valign="middle" >0.005</td><td align="center" valign="middle" >0.033</td></tr><tr><td align="center" valign="middle"  colspan="9"  >Insulin</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >65.38 &#177; 23.49</td><td align="center" valign="middle" >50.96 &#177; 25.70</td><td align="center" valign="middle" >55.12 &#177; 24.59</td><td align="center" valign="middle" >49.13 &#177; 19.14</td><td align="center" valign="middle" >56.69 &#177; 10.58</td><td align="center" valign="middle" >64.42 &#177; 22.33</td><td align="center" valign="middle" >51.68 &#177; 22.07</td><td align="center" valign="middle" >37.98 &#177; 18.18</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >42.41 &#177; 27.20</td><td align="center" valign="middle" >50.74 &#177; 25.73</td><td align="center" valign="middle" >49.25 &#177; 23.46</td><td align="center" valign="middle" >46.49 &#177; 16.53</td><td align="center" valign="middle" >51.94 &#177; 8.73</td><td align="center" valign="middle" >58.58 &#177; 21.67</td><td align="center" valign="middle" >42.91 &#177; 23.74</td><td align="center" valign="middle" >30.14 &#177; 12.55</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.964</td><td align="center" valign="middle" >0.187</td><td align="center" valign="middle" >0.421</td><td align="center" valign="middle" >0.008</td><td align="center" valign="middle" >0.153</td><td align="center" valign="middle" >0.042</td><td align="center" valign="middle" >0.006</td></tr><tr><td align="center" valign="middle"  colspan="9"  >Co-morbidities</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >46.76 &#177; 26.76</td><td align="center" valign="middle" >48.35 &#177; 25.22</td><td align="center" valign="middle" >49.45 &#177; 23.49</td><td align="center" valign="middle" >45.54 &#177; 16.92</td><td align="center" valign="middle" >52.70 &#177; 9.42</td><td align="center" valign="middle" >57.28 &#177; 21.00</td><td align="center" valign="middle" >44.72 &#177; 23.37</td><td align="center" valign="middle" >30.65 &#177; 14.32</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >70.92 &#177; 23.94</td><td align="center" valign="middle" >58.92 &#177; 25.65</td><td align="center" valign="middle" >59.52 &#177; 24.60</td><td align="center" valign="middle" >54.46 &#177; 18.72</td><td align="center" valign="middle" >58.28 &#177; 10.12</td><td align="center" valign="middle" >73.66 &#177; 21.06</td><td align="center" valign="middle" >53.30 &#177; 22.41</td><td align="center" valign="middle" >43.03 &#177; 16.46</td></tr><tr><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.056</td><td align="center" valign="middle" >0.052</td><td align="center" valign="middle" >0.019</td><td align="center" valign="middle" >0.008</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.089</td><td align="center" valign="middle" >&lt;0.001</td></tr></tbody></table></table-wrap><p>*Data presented as Mean &#177; SD, P &lt; 0.05 is considered as statistical significant value.</p></sec><sec id="s4"><title>4. Discussion</title><p>The study showed that the majority of the respondents were within the age group 50 to 60 years (33.6%) and mean age was 52.34 &#177; 10.19 years (SD). Similar study showed that the incidence of type 2 diabetes is low before age 30 years but increases rapidly and continuously with older age [<xref ref-type="bibr" rid="scirp.121109-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.121109-ref6">6</xref>]. More than half of the respondents were male (53%) and rest were female (47%). A study in Pakistan showed that out of 209 diabetic patients, 121 (57.9%) were males and 88 (42.1%) females [<xref ref-type="bibr" rid="scirp.121109-ref6">6</xref>].</p><p>Among the respondents most of them were secondary level education (37.0). The study from Greece showed that primary school education was 42.6%, middle school 19.4%, high school 18.5%, college/university 13.9% and master’s degree were 1.9% [<xref ref-type="bibr" rid="scirp.121109-ref8">8</xref>].</p><p>Majority of the respondent’s duration of diabetes were ≥1 - 4 years (51.3%), 5 - 9 years duration were 29.4% and rest of the respondents duration of diabetes were ≥10 years (19.3%). Mean duration were 5.55 &#177; 4.43 years (SD). Study on assessing health related quality of life in diabetic subjects by SF 36 questionnaire in a tertiary care diabetes unit of Karachi, Pakistan shows that duration of diabetes was &lt;5 years, 5 - 10 years, &gt;10 years [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>].</p><p>In this study most of the respondents followed diet &amp; exercise (88.2%) and rest of the respondents did not maintain diet &amp; exercise discipline (11.8%). Majority of the respondents used oral hypoglycemic agent (56.3%) for diabetes control and rest of the respondents use insulin (43.7%). Similar study of health related quality of life shows that out of 108 respondents 4.6% follow diet, 45.4% use oral hypoglycemic agent and 21.3% use insulin [<xref ref-type="bibr" rid="scirp.121109-ref8">8</xref>]. Among the respondents 76.5% were presence of co-morbidities.</p><p>The current study finding showed that the significant difference of mean score of physical functioning were in relation to age group (f = 3.728, p = 0.013). Similar findings were reported in a study from Portuguese the significant difference of physical functioning were in age (p &lt; 0.001) [<xref ref-type="bibr" rid="scirp.121109-ref10">10</xref>]. Another study in Pakistan showed the difference in age (p = 0.001) [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>]. Company showed that there is no any difference in age (p = 0.205) [<xref ref-type="bibr" rid="scirp.121109-ref11">11</xref>]. The current study also showed the difference in marital status (t = 2.488, p = 0.014), level of education (F = 3.313, p = 0.013).There is no any significant difference in sex (t = 1.495, p &gt; 0.05), religion (t = −0.209, p &gt; 0.05) and family members (F = 0.614, p &gt; 0.05) of the respondents. Similar finding of non-significant in sex were reported in a study from turkey (p = 0.080) [<xref ref-type="bibr" rid="scirp.121109-ref12">12</xref>]. But another study showed the significant difference in sex (p ≤ 0.001) [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>].</p><p>The mean score of role limitations due to physical health in relation to socio-demographic characteristics are found only in level of education (F = 3.177, 0.016) of the respondents. Similar finding was also reported in a study they showed there was no significant difference in age and sex [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.121109-ref12">12</xref>]. Similar finding in age (p &gt; 0.05) and sex (p &gt; 0.05) was reported in a study on assessing health related quality of life in diabetic subjects by SF 36 questionnaire in a tertiary care diabetes unit of Karachi, Pakistan [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>]. Another study showed the significant difference were in sex (p = 0.016) but non-significant in age (p = 0.289) [<xref ref-type="bibr" rid="scirp.121109-ref11">11</xref>].</p><p>The significant difference of mean score of energy/fatigue in relation to socio-demographic characteristics were found in only age group of the respondents (F = 4.634, p = 0.004). A study by shaheen and basit showed that the significant were in sex (p = 0.041) but there were no any relation between energy and age (p = 0.396) [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>]. Another study showed the similar finding was found in age (p &lt; 0.05) [<xref ref-type="bibr" rid="scirp.121109-ref11">11</xref>].</p><p>Mean score of emotional well-being were lower in age ≥ 60 than other age group (F = 3.206, p = 0.026). Others study reported that there were no significant difference in age (p &gt; 0.05) but they found significant in sex (p &lt; 0.05) [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>]. There is no significant difference in sex (t = 0.613, p = 0.541), religion (t = 0.059, p = 0.953), marital status (t = 1.075, p = 0.285) of the respondents in related to social functioning. The significant difference of mean score of social functioning in relation to socio-demographic characteristics are found in age group of the respondents (F = 4.989, p = 0.003) and sex of the respondents (t = −2.015, p = 0.046). The similar study on health related quality of life showed that the significant difference was not found in age and sex (p &gt; 0.05) [<xref ref-type="bibr" rid="scirp.121109-ref13">13</xref>]. Another study showed the similar finding in sex (p = 0.000) [<xref ref-type="bibr" rid="scirp.121109-ref14">14</xref>].</p><p>The significant difference of mean score of pain in relation to socio-demographic characteristics are found in the age group (F = 3.928, p = 0.010) and sex of the respondents (t = 2.408, p = 0.018). Similar finding also found in a study by Morales et al. they showed the significant in age and sex (p &lt; 0.001) [<xref ref-type="bibr" rid="scirp.121109-ref8">8</xref>]. There is no significant difference in religion (t = −0.153, p = 0.878) and education (F = 0.969, p = 0.428) in related to mean score of pain.</p><p>The significant difference of mean score of general health in relation to socio-demographic characteristics are found in age group (F = 4.442, p = 0.005) and sex (between male and female) of the respondents (t = −2.01, p = 0.046). The study from Pakistan by shaheen and basit showed no significant in age (p = 0.697) but significant in sex (p &lt; 0.001) [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>].</p><p>Relationship between duration of diabetes &gt; 10 and physical functioning (p = 0.000), energy/fatigue (p = 0.048), emotional well-being (p = 0.011), social functioning (p = 0.019), and general health (p = 0.017) were significant. Another study showed the similar finding was found in general health (0.048) [<xref ref-type="bibr" rid="scirp.121109-ref9">9</xref>]. The significant difference were found in relation between use of oral hypoglycemic agent and physical functioning (p = 0.001), energy/fatigue (p = 0.038), emotional well-being (p = 0.002), pain (p = 0.005), general health (p = 0.033).</p><p>Relation between use of insulin and physical health (p = 0.000), emotional well-being (p = 0.008), pain, (p = 0.042) and general health (p = 0.006) were significant. The significant difference in diet and exercise was related to energy/fatigue (p = 0.033). Mean score of respondents with presence of co-morbidities in physical functioning (p = 0.000), energy/fatigue (p = 0.019), emotional well-being (p = 0.008), social functioning (p = 0.000) and general health (p = 0.002) were lower than those in without co-morbidities.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The overall QoL of type-2 DM patients was poor and had a lower score of health related quality of life. Considering these related variables could lead to effective control of diabetes complications and improvement of the patients’ QoL.</p></sec><sec id="s6"><title>Statement of Ethics</title><p>Ethical clearance was taken from the IRB of NIPSOM.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Rahman, Md.M., Sultana, H., Jebin, F.M., Saha, T., Yasmeen, W., Alom, F.M.M., Jinia, S.T.F., Ahmed, S. and Ahammed, L. (2022) Health Related Quality of Life in Adult with Type 2 Diabetes Mellitus. Journal of Diabetes Mellitus, 12, 243-251. https://doi.org/10.4236/jdm.2022.124019</p></sec></body><back><ref-list><title>References</title><ref id="scirp.121109-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">D’Souza, M.S., Venkatesaperumal, R., Ruppert, S.D., Karkada, S.N. and Jacob, D. (2016) Health Related Quality of Life among Omani Men and Women with Type 2 Diabetes. Journal of Diabetes Research, 2016, Article ID: 8293579. https://doi.org/10.1155/2016/8293579</mixed-citation></ref><ref id="scirp.121109-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Porojan, M., Poant&amp;#259;, L. and Dumitra&amp;#351;cu, D.L. (2012) Assessing Health Related Quality of Life in Diabetic Patients. Romanian Journal of Internal Medicine, 50, 27-31.</mixed-citation></ref><ref id="scirp.121109-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N.H., Cavan, D., Shaw, J.E. and Makaroff, L.E. (2017) IDF Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40-50. https://doi.org/10.1016/j.diabres.2017.03.024</mixed-citation></ref><ref id="scirp.121109-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Oort, F.J. (2005) Using Structural Equation Modeling to Detect Response Shifts and True Change. Quality of Life Research, 14, 587-598. https://doi.org/10.1007/s11136-004-0830-y</mixed-citation></ref><ref id="scirp.121109-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Heidemann, C., Rabenberg, M. and Scheidt-Nave, C. (2016) Prevalence of Diabetes Mellitus. Fact Sheet on DEGS1: German Health Interview and Examination Survey for Adults (2008-2011). 1-4.</mixed-citation></ref><ref id="scirp.121109-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Davison, S.N., Bioethics, M., Frcp, C. and Jhangri, G.S. (2005) The Impact of Chronic Pain on Depression, Sleep, and the Desire to Withdraw from Dialysis in Hemodialysis Patients. Journal of Pain and Symptom Management, 30, 465-473. https://doi.org/10.1016/j.jpainsymman.2005.05.013</mixed-citation></ref><ref id="scirp.121109-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Norris, S.L. (2005) Health-Related Quality of Life among Adults with Diabetes. Current Diabetes Reports, 5, 124-130. https://doi.org/10.1007/s11892-005-0039-7</mixed-citation></ref><ref id="scirp.121109-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Zioga, E., Kazakos, K., Dimopoulos, E., Koutras, C., Marmara, K., Marmara, E., et al. (2016) Adherence and Quality of Life in Patients With Type II Diabetes Mellitus in Northern Greece. Mater Socio Medica, 28, 258-262. http://www.scopemed.org/fulltextpdf.php?mno=236957 https://doi.org/10.5455/msm.2016.28.258-262</mixed-citation></ref><ref id="scirp.121109-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Basit</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>2014</year>)<article-title>Assessing Health Related Quality of Life in Diabetic Subjects by SF 36 Questionnaire in a Tertiary Care Diabetes Unit of Karachi, Pakistan</article-title><source> International Journal</source><volume> 2</volume>,<fpage> 13</fpage>-<lpage>17</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.121109-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sepúlveda, E., Poínhos, R., Constante, M., Pais-Ribeiro, J., Freitas, P. and Carvalho, D. (2015) Health-Related Quality of Life In type 1 and Type 2 Diabetic Patients in a Portuguese Central Public Hospital. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 8, 219-226. https://doi.org/10.2147/DMSO.S80472</mixed-citation></ref><ref id="scirp.121109-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Morales, M.C., Navas, A.F., Jimenez, M.F.R. and Ramos, J.M.R. (2015) Health-Related Quality of Life in Patients with Type 2 Diabetes Mellitus in a Rural Area. Journal of Diabetes and Metabolism, 6, Article No. 1000572. https://www.omicsonline.org/open-access/healthrelated-quality-of-life-in-patients-with-type-2-diabetes-mellitus-in-a-rural-area-2155-6156-1000572.php?aid=54519https://doi.org/10.4172/2155-6156.1000572</mixed-citation></ref><ref id="scirp.121109-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Sara&amp;#231;, Z.F., Tütüncüo, P., Par, S., Sayg, F., Cande, Y. and Tüzün, M. (2007) 41 Quality of Life in Turkish Diabetic Patients. Turkish Journal of Endocrinology and Metabolism, 11, 48-53.</mixed-citation></ref><ref id="scirp.121109-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Saleh, F., Ara, F., Mumu, S.J. and Hafez, M.A. (2015) Assessment of Health-Related Quality of Life of Bangladeshi Patients with Type 2 Diabetes Using the EQ-5D: A Cross-Sectional Study. BMC Research Notes, 8, Article No. 497. https://doi.org/10.1186/s13104-015-1453-9</mixed-citation></ref><ref id="scirp.121109-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Ghaem, H., Fakherpour, A., Hajipour, M. and Shafiee, M. (2016) Quality of Life and Associated Factors among Elderly Diabetic Patients in Shiraz, 2014. Journal of Health Sciences &amp; Surveillance System, 4, 129-136.</mixed-citation></ref></ref-list></back></article>